Wachovia Starts MAKO Surgical (MAKO) at Market Perform
More News related to MAKO
- Lazard Capital Initiates Coverage on MAKO Surgical (MAKO) with a Buy
- Lazard Starts MAKO Surgical (MAKO) at Buy
- MAKO Surgical Corp. to Present At the Morgan Stanley Global Healthcare Unplugged Conference
- MAKO Surgical Corp. Reports Operating Results for the Second Quarter 2008
- MAKO Surgical Corp. Schedules 2008 Second Quarter Earnings Release and Conference Call for Tuesday, July 29, 2008
More News related to New Coverage
- Caris & Co Initiates Coverage on C. R. Bard (BCR) with an Above Average
- Caris & Co Initiates Coverage on Cinemark (CNK)
- Caris & Co Initiates Coverage on Medtronic (MDT) with an Average Rating
- Caris & Co Initiates Coverage on St. Jude (STJ)
- Sterne Agee Initiates Coverage Engineering & Heavy Construction Stocks CBI, FLR, JEC, SGR and FWLT
Wachovia initiates coverage on MAKO Surgical (Nasdaq: MAKO) with a Market Perform rating and a $10-$11 valuation range.
The firm believes that MAKO's robotic-arm system, the Tactical Guidance System, will be an active member in pushing the bar in orthopedics. Wachovia sees MAKO targeting about 8% of the U.S. market for unicompartmental knee arthroplasty, or about 46,000 replacements over 2008.
Wachovia says "the surgical world is in the early stages of adopting computer assisted surgery", and places MAKO as a leader in this area of medical devices.
The firm expects MAKO to offer a version 2.0 of its device to be launched in mid-2009, at which time Wachovia believes adoption of the device to begin ramping more dramatically.
MAKO Surgical Corp., a medical device company, provides advanced robotic solution and orthopedic implants for minimally invasive orthopedic knee procedures. [BCS]
Related Categories
New CoverageStocks Mentioned
+0.23Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
